Please enable Javascript on your browser for a better experience.
The Measles IgG IgM Antibodies Test measures immune response to the measles virus by detecting IgM for recent or acute infection and IgG for past exposure or vaccine immunity. This test helps confirm suspected measles cases in patients with fever, rash, cough, or conjunctivitis, and evaluates immunity in those with uncertain vaccination history, supporting diagnosis, outbreak control, and public health monitoring.
The Measles IgG Antibody Test measures IgG antibodies to determine immunity from past infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to measles. Doctors use this blood test to confirm immune status, evaluate vaccination records, or meet school, travel, or employment requirements. It provides valuable insight into measles protection and public health safety.
The Measles Titer Test measures IgG antibody levels to determine immunity from prior measles infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility. Doctors order this test to confirm immune status for school, healthcare, travel, or employment requirements. It is also used to verify vaccination response, ensuring individuals are protected against measles and reducing outbreak risk.
The Measles IgM Antibody Test detects IgM antibodies specific to the measles virus, providing evidence of recent or acute infection. IgM antibodies typically appear shortly after exposure and indicate an active immune response. This test is used to confirm measles in symptomatic patients, support outbreak investigations, and distinguish between current infection and prior immunity, aiding timely clinical and public health decisions.
The Measles, Mumps, Rubella (MMR) Immunity Profile is a quantitative blood test that measures antibody levels to measles, mumps, and rubella. Results confirm prior infection or vaccine response and show if antibody levels are protective. Doctors order this test for school, employment, or travel requirements, to evaluate vaccine effectiveness, and to guide revaccination decisions. It provides reliable assessment of immune protection against all three viral diseases.
The MMR Titer Test is a quantitative blood test that measures antibody levels to measles, mumps, and rubella. Results provide exact antibody values to confirm prior infection or response to vaccination. Low levels suggest lack of protection, while higher levels indicate adequate response. Doctors order this test for school, employment, or travel requirements and to guide revaccination decisions, ensuring accurate evaluation of immune status against these viral diseases.
The Rubella IgM Antibody Test measures immune response to the rubella virus by identifying IgM antibodies produced soon after exposure. Detection of rubella IgM helps diagnose recent infection, assess rash-related illness, and monitor risk in pregnancy where congenital rubella syndrome may occur. This test provides valuable insight into acute infection, immunity status, and systemic health.
The Immunity Panel Plus is a comprehensive set of tests designed to evaluate an individual's immunity to certain infectious diseases. This panel includes tests for Hepatitis A Antibody Total, Hepatitis B Surface Antibody, Quantitative, Measles IgG Antibody, Mumps IgG Antibody, Rubella IgG Antibody, and Varicella-Zoster Virus IgG Antibody. It is often used to determine if an individual has immunity, either from previous infections or vaccinations, against these specific diseases.
The Student Titers Panel evaluates immunity to key infections often required for school or healthcare enrollment. It includes Hepatitis B Surface Antibody, Measles IgG, Mumps IgG, Rubella IgG, Varicella-Zoster Virus IgG, and QuantiFERON-TB Gold Plus for tuberculosis. Results confirm vaccination response or past exposure, helping students meet program requirements and ensure protection against preventable diseases.
The Rubella Titer Test measures IgG antibodies to determine immunity to rubella (German measles). A positive result indicates protection from prior infection or vaccination, while a negative result suggests susceptibility. Doctors order this test for women planning pregnancy, healthcare workers, students, or travelers. It helps confirm immune status, guide vaccination needs, and protect against congenital rubella syndrome and outbreak risks.
The Rubella IgG IgM Antibodies Test measures antibodies to the rubella virus, helping evaluate immunity or recent infection. IgM indicates an active or recent infection, while IgG confirms past infection or vaccination. Doctors use this test to assess immune status in women of childbearing age, screen during pregnancy, or confirm suspected rubella exposure, as infection can cause serious complications for unborn babies.
The Mumps Virus Titer Test measures IgG antibodies to determine immunity from prior infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to mumps. Doctors use this blood test to confirm immune status, check vaccine response, or meet school, travel, or employment requirements. It provides valuable information for individual protection and public health safety.
